All PHIOGEN articles
-
NewsPHIOGEN announces collaboration with Live UTI Free to drive patient-focused clinical trials
A biotech company developing live biotherapeutic products for drug-resistant and recurrent bacterial infections, is collaborating with a patient research and advocacy organization to empower their clinical development efforts.
-
NewsBiotech spinoff PHIOGEN to tackle threat of antimicrobial resistance
A new biotech spin-off, PHIOGEN, has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections.